"3 by 5" progress December 2005 Progress on global access to HIV antiretroviral therapy | 12 April 2015 2 |2 | Antiretroviral therapy coverage in low-

"3 by 5" progress December 2005

Progress on global access to HIV antiretroviral therapy | 18 April 20232 |

Antiretroviral therapy coverage in low- and middle-income countries, December 2005

Geographical RegionNumber of people receiving ARV therapy

Estimated need

Coverage

   (low estimate – high estimate)

Sub-Saharan Africa810 000 (730 000 –890 000)4 700 00017%

Latin America and the Caribbean315 000 (295 000 –335 000)465 00068%

East, South and South-East Asia180 000(150 000 –210 000)1 100 00016%

Europe and Central Asia21 000 (20 000 – 22 000)160 00013%

North Africa and the Middle East4 000(3 000 –5 000)75 0005%

Total1 330 000(1 200 000 –1 460 000)6.5 million20%

Progress on global access to HIV antiretroviral therapy | 18 April 20233 |

Number of people receiving ARV therapy in low and middle income countries, 2002—2005

end2002

mid-2003

end2003

mid-2004

end2004

mid-2005

end2005

0

100

200

300

400

500

600

700

800

900

1 000

1 100

1 200

1 300

1 400

Pe

op

le r

ec

eiv

ing

AR

V t

he

rap

y (

in t

ho

us

an

ds

)

North Africa and the Middle East

Europe and Central Asia

East, South and South-East Asia

Latin America and the Caribbean

Sub-Saharan Africa

Progress on global access to HIV antiretroviral therapy | 18 April 20234 |

Percentage of people on antiretroviral therapy among those in need, December 2005

5

Percentage of people in sub-Saharan Africa on antiretroviral therapy among those in need

6

Scaling up of antiretroviral therapy in Malawi, 2003—2005

Progress on global access to HIV antiretroviral therapy | 18 April 20237 |

Annual number of AIDS deaths projected among adults in sub-Saharan Africa under different

intervention scenarios, 2003—2020

0.0

0.5

1.0

1.5

2.0

2.5

3.0

2003 2005 2007 2009 2011 2013 2015 2017 2019

Year

Mill

ion

sBaseline

Treatment-centred

Prevention-centred

Comprehensive response

8

Percentage of women among all adults receiving antiretroviral therapy, 2005

9

Success rate of grant proposals to the Global Fund in Round 4 with and without technical

support from WHO or UNAIDS

17%

44%

36%

62%

22%

56%

25%

51%

HIV/AIDS Malaria Tuberculosis Total

Without WHO or UNAIDS assistanceWHO or UNAIDS assisted

Progress on global access to HIV antiretroviral therapy | 18 April 202310 |

Trends in the cost of first-line antiretroviral therapy regimens in low-income countries, overlaid with the number of people treated,

2003—2005

0

100

200

300

400

500

600

700

2003 2004 2005

Stavudine + lamivudine +nevirapine (US$ per person peryear)

Zidovudine + lamivudine +efavirenz (US$ per person peryear)

Number of people treated at end ofthe year (in thousands)

Progress on global access to HIV antiretroviral therapy | 18 April 202311 |

Global HIV/AIDS spending in millions of US dollars, 1996—2004

0

1 000

2 000

3 000

4 000

5 000

6 000

7 000

Mil

lio

ns o

f U

S d

oll

ars

1996 2000 2001 2002 2003 2004

Year

Domestic

Private

Multilateral

Bilateral

Progress on global access to HIV antiretroviral therapy | 18 April 202312 |

Development of policies for collaborative TB/HIV activities in 32 countries, 2002—2004

0

5

10

15

20

25

Nu

mb

er

of

co

un

trie

s

TB/HIV focalpoint in nationalTB programme

Formal referralsystem from HIV

to TB

Intensified TBcase-finding

HIV testing forpeople with TB

Co-trimoxazolepreventive

therapy

Antiretroviraltherapy

2002

2003

2004

Progress on global access to HIV antiretroviral therapy | 18 April 202313 |